Positive CD44v9 mRNA expression and high CEA were observed in 2 out of 72 cases with stage I, 4 out of 82 cases with stage II, 12 out of 85 cases with stage III, and 21 out of 61 cases with stage IV of CRC. The gene discussed is CEACAM5; the disease is colorectal carcinoma.